Clinical Trial Update: High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial of high-dose chemotherapy with rituximab in adults with aggressive diffuse large B-cell lymphoma. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Nantes University Hospital | Conditions: B-Cell Lymphoma | Phase 2 | Status: COMPLETED